Skip to main content
OpenTrials
Completed

NCT Number: NCT00695591

Home Sleep Testing in Neuromuscular Disease Patients

Lay Summary Patients with severe neuromuscular develop hypoventilation, which leads to elevated carbon dioxide levels. Measuring only oxygen saturation levels with pulse oximetry may be inadequate. End tidal carbon dioxide levels or arterial blood gases should be measured periodically, depending on the clinical condition of the patient. A thorough review of systems will help define any problems. Patients who are hypoventilating often have elevated carbon dioxide levels at night and complain of a morning headache, restlessness or nightmares, and poor quality sleep. This may cause daytime sleepiness. Insufficient respiration with hypoxia may occur later, especially if the lung is damaged by chronic aspiration.

We propose to evaluate the use of the Nonin LifeSense monitor in home evaluation of respiration, oxygen level, heart rate, and carbon dioxide level and to develop interpretation of the results that will lead to appropriate interventions for apnea, and insufficient respiration.

Relevance to MDA Fewer than one per cent of the Muscular Dystrophy Association have pulmonologists as co-directors.Late referral of progressive restrictive lung disease leads to invasive support of respiratory failure. Early initiation of non invasive ventilation techniques requires patience on the part of the caregiver and exploration of mask interfaces and ventilation techniques. In addition, the development of new therapies, currently manifested through enhanced diagnostic accuracy, will require new signal for initiation and in the assessment of success or failure.

Aims Aim 1. To assess the utility of a small portable device (LifeSense Monitor Nonin Medical Inc. Plymouth Minnesota) with extended recording capabilty to provide accurate diagnosis of hypoventilation.

Aim 2. To provide an easily interpretable report defining sleep hypoxemia, hypercapnea, and apnea.

Aim 3. To promote early evaluation and treatment of the respiratory problems in centers that do not have pumonologists as these are essential to prognosis, whether of survival or of quality of life, in neuromuscular diseases.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pediatric Diagnostic Center

Ventura, California, 93003, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of neuromuscular disease
  • Must have home caregivers

Exclusion criteria

  • No home caregiver

Treatment and study plan

Evaluation for Nocturnal non invasive ventilation

Other

Patients will be referred for evaluation for NNIV is indicated in patients with diurnal Pa,CO2 >6.0 Pa; and 2) nocturnal Sa,O2 <88% for 5 consecutive min. End tidal CO2 representing equivalent values will be referred for NNIV

Primary outcomes

  1. 1. End tidal CO2 catheter is tolerated for six hours or more

    Time frame: 3 months

Secondary outcomes

  1. 1. Interpretable data are captured for oximetry, heart rate, and end-tidal CO2

    Time frame: 3 months

  2. 2. An interpretive report is generated that will guide the non-pulmonary physician in potential interventions

    Time frame: 6 months

  3. 2. Patients and parents are able to apply the monitors at home and a six hour data set is collected

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Landon Pediatric Foundation

Other

Registry information

Acronym: HSTNMD

Important dates

Study start
2008
Primary completion
2008
Study completion
2009
First posted
Jun 12, 2008
Registry last updated
Aug 13, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.